Navigation Links
Remicade in Medical News

Driven by Sales of Enbrel, Remicade and Humira, spondyloarthropathies Drug Market Grew to Nearly $2 Billion in 2008

Newly Approved Simponi is Expected to Achieve Strong Uptake in this Niche Market, According to a New Report from Decision Resources WALTHAM, Mass., April 30 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, fin...

For Ulcerative Colitis, Surveyed Experts Indicate That Corticosteroids Have Advantages Over Remicade in the Induction of Remission

Abbott/Eisai's Humira Will Earn Decision Resources' Clinical Gold Standard Status for Ulcerative Colitis in 2012, According to a New Report from Decision Resources WALTHAM, Mass., April 16 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceu...

Surveyed Gastroenterologists Indicate That Humira Has Advantages Over Remicade in Maintaining Clinical Remission of Crohn's Disease

Humira Will Retain its Status as Decision Resources' Clinical Gold Standard for Crohn's Disease Through 2017, According to a New Report from Decision Resources WALTHAM, Mass., Jan. 26, /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceuti...

Humira to Replace Remicade as First Choice Among Biologics for the Treatment of Crohn's Disease

Oral 5-Aminosalicylates Will Continue to be Used in Early Lines of Therapy, According to a New Report from Decision Resources WALTHAM, Mass., Oct. 27 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, f...

A Drug With Efficacy Superior to That of Remicade at Inducing Closure and Healing of Fistulas Would Earn a 30 Percent Patient Share in the Crohn's Disease Drug Market

Ustekinumab Will Earn a 5.4 Percent Patient Share by 2012, According to a New Report from Decision Resources WALTHAM, Mass., June 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, fin...

Although Remicade and Humira Are Being Increasingly Prescribed for Crohn's Disease and Ulcerative Colitis, Insurers Are Subjecting Both Drugs to Multiple Cost-Control Strategies

Nearly One-Third of Surveyed Managed Care Organizations Levy Coinsurance Charges and Other Protocols on Remicade and Humira, According to a New Report from Decision Resources WALTHAM, Mass., March 4 /PRNewswire/ -- Decision Resources, one of the world's leading research ...

U.S. Payers Intend to Limit Preferred Coverage to Only One Immune Biologic

...Control Offers Opportunities for Differentiation , Centocor Ortho Biotech's remicade and Abbott's Humira stand to most directly benefit from this strategy as th...ogic, therapeutic area tenders may help some brands remain competitive with remicade and Humira," said Michael Malecki, Ph.D., product manager for Formulary For...

Certain Arthritis, Crohn's Drugs May Raise Kids' Cancer Risk: FDA

... Agency strengthens 'black box' warning on medicines such as Enbrel, remicade TUESDAY, Aug. 4 (HealthDay News) -- Drugs widely used to fight ... inflammation and damage to bones, cartilage and other tissue. They include remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizuma...

Brazil's Rheumatoid Arthritis Drug Market Will Grow $115 Million by 2013

...e than $315 million in 2013. The 2008 market leaders were the tumor necrosis factor-alpha (TNF-alpha) inhibitors Abbott's Humira and Schering-Plough's remicade which recorded sales of $50 million and $43 million, respectively, despite a combined patient share of two percent. Wyeth's Enbrel, the third marketed...

Intravenous Immune Biologics Will Suffer from the Pending Shift in Coverage from the Medical to the Pharmacy Benefit

...ical benefit to a pharmacy benefit by 2014, citing Centocor Ortho Biotech's remicade and UCB's Cimzia among products that will be most affected by this shift. A...utlays--in part due to physicians preferentially prescribing agents such as remicade so the physician can purchase the agent at a discount relative to the reimb...
Remicade in Medical Technology

New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease

... First-of-its-Kind Study Demonstrates remicade More Likely to Maintain Steroid-Free Remission in ...ed that a greater proportion of patients receiving remicade (infliximab) maintained steroid-free remission at ...nvestigator. "The data further support the use of remicade earlier in the treatment of moderate to severe Cro...

New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study

... Data from SONIC Trial Showed remicade Therapy is More Likely to Induce Steroid-Free Re... that at week 26, 57 percent of patients receiving remicade combination therapy and 44 percent of patients receiving remicade monotherapy achieved steroid-free remission, the p...

New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease

...eported at weeks 8 and 30 among patients receiving remicade and meeting the disease duration criteria. These f... "These data are encouraging because we see that remicade is an effective treatment option for patients with...Regardless of disease duration, patients receiving remicade showed significant improvements in clinical respon...

REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body

...y 1,500 subjects, 71 percent of patients receiving remicade 3 mg/kg and 79 percent of patients receiving remicade 5 mg/kg achieved a PASI 75, or at least a 75 perce...y, 39 percent and 52 percent of patients receiving remicade 3 mg/kg and 5 mg/kg, respectively, achieved a PASI...

Long-Term Extension of Ulcerative Colitis Study Shows Remicade Responders Maintained Improvement Through Two Years of Follow-Up

... "The data demonstrate the sustained efficacy of remicade for many patients with UC," said co-principle inve...=364). The 728 patients were randomized to receive remicade 5 mg/kg, remicade 10 mg/kg or placebo at weeks 0, 2, 6 and every sub...

Remicade Two Year Data in Ankylosing Spondylitis Show Improvement in Spinal Mobility and Spinal Inflammation

...resonance imaging (MRI). The recommended dose of remicade in AS is 5 mg/kg given as an IV induction regimen ...were analyzed to determine the long-term effect of remicade on spinal mobility. The double-blind extension of ...ASMI and chest expansion scores as patients in the remicade group at weeks 54, 78 and 102. "Ankylosing spond...
Remicade in Medical Products

AHFS Patient Drug Information

Features:...pliance. Empower patients to be more active and involved in their treatment. New and updated drug information includes: Pepcid, Flonase, Paxil, remicade With Skyscape's patented smARTlink™ technology, FamilyRx™ can easily cross-index with other titles from Skyscape to provide a powerful a...
Company:Skyscape, Inc.
Remicade in Biological News

Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients

PHILADELPHIA, PA, October 15, 2007- Clinical data presented today at the annual meeting of the American College of Gastroenterology (ACG) show that REMICADE significantly reduces the incidence of colectomy surgeries for patients with moderately to severely active ulcerative colitis (UC). Accordin...
Remicade in Biological Technology

Schering-Plough Reports Financial Results for 2009 Second Quarter

...ion. "Our diverse product strength - from remicade to TEMODAR to NUVARING to MIRALAX - and our rich g... foreign exchange of 10 percent. Sales of remicade increased 2 percent (19 percent operational growth...d quarter of 2009 due to continued market growth. remicade is a treatment for inflammatory diseases that Sche...

CBDM.T, The Market and Business Intelligence Company Reviews The Biomanufacturing Market

...s sold in the US. The top 5 leading biotech drugs sold in the USA are Enbrel (Amgen, Wyeth), Aranesp (Amgen), Rituxan (Biogen Idec, Genentech, Roche), remicade (Johnson & Johnson, Schering-Plough) and Procrit (Johnson and Johnson). According to CBDMT®, contract biomanufacturing is a significant ma...

Schering-Plough Reports Financial Results for First Quarter of 2008

...ated to Organon, the OBS human health business acquired in 2007. Sales of remicade increased 36 percent to $507 million in the first quarter of 2008 due to co...HUMAN PRESCRIPTION PHARMACEUTICALS a/ $3,557 $2,398 48% remicade 507 373 36% NASONEX ...

Unmet Needs Provide Challenges and Opportunities for Rheumatoid Arthritis Drug Developers According to MedPredict Report

...e most promising candidates." Drugs/Companies mentioned in this report: allopurinol; febuxostat (Teijin/Ipsen/TAP); Puricase (pegloticase; Savient); remicade (infliximab; Centocor/Schering-Plough/Essex), Enbrel (etanercept; Wyeth/Amgen); Humira (adalimumab; Abbott), Orencia (abatacept; Bristol-Myers Squibb)...

Centocor/Janssen-Cilag's Ustekinumab Will Become the Gold Standard for Psoriasis By 2011

...numab will achieve gold standard status because of its competitive advantages in long-term efficacy over Centocor/Schering- Plough/Mitsubishi Tanabe's remicade and due to its superior effect on plaque clearance when compared to Amgen/Wyeth/Takeda's Enbrel. According to the new report entitled Psoriasis: Ust...

Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year

...Organon, the OBS human health business. Sales of remicade increased 35 percent to $455 million in the fourth...market growth and expanded use across indications. remicade is a treatment for inflammatory diseases that Sche...nt, commercialization and distribution of both remicade (infliximab) and golimumab. (Announced Dec. 21, 2...

REMICADE(R) Becomes First Anti-TNF Biologic Therapy to Treat One Million Patients Worldwide

...sis factor (TNF)-alpha therapy worldwide. In fact, remicade has been used to treat more patients worldwide than all other anti-TNF-alpha agents combined. remicade was the first anti-TNF-alpha treatment approved by...early impossible. It's hard to put into words what remicade has meant to me." Through a long line of firsts i...
Other Tags
(Date:10/20/2014)... (PRWEB) October 20, 2014 JZ Fitness, ... nutritional coaching, corporate wellness programming, authorship, international lecturing and ... excited to announce the release of the JZ Fitness ... many years of coaching thousands of individuals on nutrition, ... app that does not require calorie counting or cumbersome ...
(Date:10/20/2014)... 20, 2014 Principle Business Enterprises, a ... in manufacturing top-of-the-line absorbent products. The company has ... most popular brand, Tranquility® Premium Protection absorbent products. ... website, gave its packaging a new look, and is ... message to the public. , The new website, developed ...
(Date:10/20/2014)... 20, 2014 Myoderm ... Assistant Director of their CentralSource service. ... the innovative turnkey drug sourcing, distribution, and management ... over 12 years of industry experience, in both ... the peak of their international success to help ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Succeed is proud ... local companies who participated in the Every Body Walk! ... a public awareness project that encourages workers to be more ... Step 10,000 Program, which concluded at the end of September, ... of cities and metro areas. Participating companies gave their ...
(Date:10/20/2014)... 20, 2014 National Teen Driver Safety Week ... American Academy of Pediatrics (Ohio AAP, http://www.ohioaap.org ) is ... parents of teen drivers to talk to their teens and ... Motor vehicle crashes are the leading cause of death for ... in fatal crashes, and 859 (42%) of those teen drivers ...
Breaking Medicine News(10 mins):Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Myoderm Hires Matthew Voicheck to Lead Turnkey Drug Sourcing Service 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2
(Date:10/15/2014)... Oct. 15, 2014   Neurotechnology , a ... the availability of the VeriLook Surveillance 3.0 ... provides real-time biometric face identification using live video ... cameras. The new version not only identifies faces ... from objects while they are moving through the ...
(Date:10/14/2014)... years since T. rex took its last ... is breathing life back into dinosaurs using high-powered computer ... has important implications for how dinosaurs used their noses ... of smell and cool their brains. , "Dinosaurs ... Jason Bourke, lead author of the new study published ...
(Date:10/14/2014)... a new kind of stem cell that can become either ... vessels, according to a study published today in the journal ... cell type contradicts current theory on how organs arise from ... origins of, and future treatment for, liver cancer., Thanks to ... complex being made up of more than 200 cell types. ...
Breaking Biology News(10 mins):VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3
Other Contents